Effects of rosiglitazone on the serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes

Atamer, A.Selek, S.Kocyigit, Y.Ilhan, N.Sen, T.Atamer, Y.2024-04-242024-04-2420071567-5688https://doi.org/10.1016/S1567-5688(07)71699-9https://hdl.handle.net/11468/1635976th Congress of the European-Atherosclerosis-Society -- JUN 10-13, 2007 -- Helsinki, FINLAND[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Effects of rosiglitazone on the serum paraoxonase activity and metabolic parameters in patients with type 2 diabetesEffects of rosiglitazone on the serum paraoxonase activity and metabolic parameters in patients with type 2 diabetesConference Object81184185WOS:00024786910074710.1016/S1567-5688(07)71699-9Q1